Genetically Proxied Telomere Length but Not Epigenetic Aging Acceleration Causally Influences Healthspan: A Mendelian Randomization Study
Bowen FengiD, Robert Yang, Gabriella R Wang, Qiu Hu, Chuntao ZhaoiD
Abstract
ObjectiveTo assess the causal effects of leukocyte telomere length (TL) and epigenetic age acceleration (EAA) on healthspan. MethodsWe performed two-sample Mendelian randomization (MR) analyses in accordance with STROBE-MR guidelines. Genetic instrumental variables (IVs) for TL and four EAA biomarkers (Hannum, GrimAge, PhenoAge, and intrinsic EAA) were derived from published genome-wide association study (GWAS) summary statistics involving up to 472,174 individuals for TL and approximately 35,000 individuals for each EAA biomarker. GWAS summary statistics for healthspan, defined as age at first diagnosis of any of eight major chronic conditions or death, were obtained from the UK Biobank (N=300,477 unrelated European-ancestry participants). The primary MR estimates were obtained using the inverse-variance weighted (IVW) method, complemented by various sensitivity analyses to assess pleiotropy, instrument heterogeneity, and robustness of causal inference. The strength of the IVs was evaluated using F-statistics, and causal directionality was validated using Steiger filtering. ResultsGenetically predicted longer TL was causally associated with extended healthspan (IVW {beta}=0.106; 95% CI: 0.053-0.159; p=6.9x10-5). The association was robust across multiple sensitivity analyses, with no indication of directional pleiotropy (MR-Egger intercept p=0.47), no influential outliers identified by MR-PRESSO, and consistent causal direction confirmed by Steiger tests. In contrast, none of the four EAA biomarkers demonstrated convincing causal effects on health span (all IVW p-values >0.05), and results were inconsistent across sensitivity analyses, suggesting their role as correlates rather than causal determinants of healthy longevity. ConclusionsThis MR study provides robust evidence supporting a causal role of genetically determined telomere length in extending healthspan, while no such effect was observed for four commonly studied EAA biomarkers. These findings underscore the central role of telomere biology in healthy aging and indicate that telomere maintenance may represent a promising target for interventions aimed at delaying the onset of age-related diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Breaking down causes, consequences, and mediating effects of age-related telomere shortening on human health
Samuel Moix, Marie C. Sadler, … Chiara Auwerx·Genome biologyPeer-reviewed·May 17, 2024
- A Mendelian randomization study of telomere length and blood-cell traits
Charleen D. Adams, Brian B. Boutwell·Scientific ReportsPeer-reviewed·Jul 22, 2020
- GWAS of epigenetic ageing rates in blood reveals a critical role for TERT
Ake Tzu-Hui Lu, Luting Xue, … Steve Horvath·bioRxiv·Jun 30, 2017
- A Trans-Omic Mendelian Randomization Study of Parental Lifespan Uncovers Novel Aging Biology and Drug Candidates for Human Healthspan Extension
Nicolas Perrot, William Pelletier, … Benoît J. Arsenault·Aging CellPeer-reviewed·Oct 27, 2021
- Genetic, parental and lifestyle factors influence telomere length
S. Andreu-Sanchez, G. Aubert, … A. Zhernakova·bioRxiv·Dec 14, 2021
- Determinants of telomere length across human tissues
Kathryn Demanelis, Farzana Jasmine, … Xiaoquan Wen·SciencePeer-reviewed·Sep 10, 2020